The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Arterial Occlusive Diseases

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Arterial Occlusive Diseases


High impact information on Arterial Occlusive Diseases


Chemical compound and disease context of Arterial Occlusive Diseases


Biological context of Arterial Occlusive Diseases


Anatomical context of Arterial Occlusive Diseases


Gene context of Arterial Occlusive Diseases


Analytical, diagnostic and therapeutic context of Arterial Occlusive Diseases


  1. Hyperhomocysteinemia and venous thromboembolic disease. D'Angelo, A., Mazzola, G., Crippa, L., Fermo, I., Viganò D'Angelo, S. Haematologica (1997) [Pubmed]
  2. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients. Gemmati, D., Serino, M.L., Trivellato, C., Fiorini, S., Scapoli, G.L. Haematologica (1999) [Pubmed]
  3. Analysis of 45 episodes of arterial occlusive disease in Japanese patients with congenital protein C deficiency. Sakata, T., Kario, K., Katayama, Y., Matsuyama, T., Kato, H., Miyata, T. Thromb. Res. (1999) [Pubmed]
  4. Genetics of hyperhomocysteinaemia in cardiovascular disease. Lievers, K.J., Kluijtmans, L.A., Blom, H.J. Ann. Clin. Biochem. (2003) [Pubmed]
  5. Wavelet de-noising of laser Doppler reactive hyperemia signals to diagnose peripheral arterial occlusive diseases. Humeau, A., Koitka, A., Saumet, J.L., L'Huillier, J.P. IEEE transactions on bio-medical engineering. (2002) [Pubmed]
  6. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. Malinow, M.R., Duell, P.B., Hess, D.L., Anderson, P.H., Kruger, W.D., Phillipson, B.E., Gluckman, R.A., Block, P.C., Upson, B.M. N. Engl. J. Med. (1998) [Pubmed]
  7. Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication. De Cree, J., Leempoels, J., Geukens, H., Verhaegen, H. Lancet (1984) [Pubmed]
  8. Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. Konstantopoulos, K., Kamat, S.G., Schafer, A.I., Bañez, E.I., Jordan, R., Kleiman, N.S., Hellums, J.D. Circulation (1995) [Pubmed]
  9. Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study. Coccheri, S., Scondotto, G., Agnelli, G., Palazzini, E., Zamboni, V. Eur. Heart J. (2002) [Pubmed]
  10. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Schoneveld, A.H., Oude Nijhuis, M.M., van Middelaar, B., Laman, J.D., de Kleijn, D.P., Pasterkamp, G. Cardiovasc. Res. (2005) [Pubmed]
  11. Long-term follow-up of patients having infrainguinal bypass performed below stenotic but hemodynamically normal aortoiliac vessels. Kikta, M.J., Flanigan, D.P., Bishara, R.A., Goodson, S.F., Schuler, J.J., Meyer, J.P. J. Vasc. Surg. (1987) [Pubmed]
  12. Prostaglandin E1 and arterial occlusive disease: pharmacological considerations. Simmet, T., Peskar, B.A. Eur. J. Clin. Invest. (1988) [Pubmed]
  13. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease: effects of vascular therapy on spectroscopic results. Schunk, K., Romaneehsen, B., Rieker, O., Düber, C., Kersjes, W., Schadmand-Fischer, S., Schmiedt, W., Thelen, M. Investigative radiology. (1998) [Pubmed]
  14. Homocyst(e)ine and arterial occlusive diseases. Malinow, M.R. J. Intern. Med. (1994) [Pubmed]
  15. Prostacyclin treatment of ischemic ulcers and rest pain in unreconstructible peripheral arterial occlusive disease. Cronenwett, J.L., Zelenock, G.B., Whitehouse, W.M., Lindenauer, S.M., Graham, L.M., Stanley, J.C. Surgery (1986) [Pubmed]
  16. Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease. Renner, W., Köppel, H., Brodmann, M., Pabst, E., Schallmoser, K., Toplak, H., Wascher, T.C., Pilger, E. Thromb. Haemost. (2000) [Pubmed]
  17. A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels. Lievers, K.J., Kluijtmans, L.A., Heil, S.G., Boers, G.H., Verhoef, P., van Oppenraay-Emmerzaal, D., den Heijer, M., Trijbels, F.J., Blom, H.J. Eur. J. Hum. Genet. (2001) [Pubmed]
  18. Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases, a double-blind study versus placebo. Katsumura, T., Mishima, Y., Kamiya, K., Sakaguchi, S., Tanabe, T., Sakuma, A. Angiology. (1982) [Pubmed]
  19. Usefulness of hemodynamic evaluation in patients with major cerebral arterial occlusive disease before cardiac surgery. Kitahara, T., Kashiwagi, S., Kato, S., Moroi, J., Shirao, S., Nogami, K. The Keio journal of medicine. (2000) [Pubmed]
  20. Hemorheology and walking of peripheral arterial occlusive diseases patients during treatment with Ginkgo biloba extract. Li, A.L., Shi, Y.D., Landsmann, B., Schanowski-Bouvier, P., Dikta, G., Bauer, U., Artmann, G.M. Zhongguo yao li xue bao = Acta pharmacologica Sinica. (1998) [Pubmed]
  21. Performance of the vascular physical examination by residents and medical students. Endean, E.D., Sloan, D.A., Veldenz, H.C., Donnelly, M.B., Schwarcz, T.H. J. Vasc. Surg. (1994) [Pubmed]
  22. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation. Saeki, S., Yamamura, K., Matsushita, M., Nishikimi, N., Sakurai, T., Nimura, Y. International journal of clinical pharmacology and therapeutics. (1998) [Pubmed]
  23. The effect of caffeine on peripheral vascular resistance in isolated perfused guinea pig hind limbs. Brodmann, M., Lischnig, U., Lueger, A., Pilger, E., Stark, G. J. Cardiovasc. Pharmacol. (2003) [Pubmed]
  24. Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo. van Weel, V., Deckers, M.M., Grimbergen, J.M., van Leuven, K.J., Lardenoye, J.H., Schlingemann, R.O., van Nieuw Amerongen, G.P., van Bockel, J.H., van Hinsbergh, V.W., Quax, P.H. Circ. Res. (2004) [Pubmed]
  25. Hereditary protein S deficiency in young adults with arterial occlusive disease. Allaart, C.F., Aronson, D.C., Ruys, T., Rosendaal, F.R., van Bockel, J.H., Bertina, R.M., Briët, E. Thromb. Haemost. (1990) [Pubmed]
  26. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Pasterkamp, G., Van Keulen, J.K., De Kleijn, D.P. Eur. J. Clin. Invest. (2004) [Pubmed]
  27. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease. Matsui, K., Ikeda, U., Murakami, Y., Yoshioka, T., Shimada, K. Am. Heart J. (2003) [Pubmed]
  28. Plasma levels of tumor necrosis factor and endothelial response in patients with chronic arterial obstructive disease or Raynaud's phenomenon. Cimminiello, C., Arpaia, G., Toschi, V., Rossi, F., Aloisio, M., Motta, A., Bonfardeci, G. Angiology. (1994) [Pubmed]
  29. Controlled trial of suloctidil in intermittent claudication. Verhaeghe, R., Van Hoof, A., Beyens, G. J. Cardiovasc. Pharmacol. (1981) [Pubmed]
  30. Buflomedil in arterial occlusive disease: results of a controlled multicenter study. Trübestein, G., Balzer, K., Bisler, H., Klüken, N., Muller-Wiefel, H., Unkel, B., Mahfoud, Y., Ziegler, W. Angiology. (1984) [Pubmed]
  31. Transcutaneous PO2 and laser Doppler flowmetry in patients with arterial occlusive disease receiving intraarterial infusions of PGE1 or nucleotide phosphates. Caspary, L., Creutzig, A., Alexander, K. Prog. Clin. Biol. Res. (1987) [Pubmed]
WikiGenes - Universities